Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » Colorado Center for Personalized Medicine Biobank Begins Returning Participant PGx Results

Colorado Center for Personalized Medicine Biobank Begins Returning Participant PGx Results

Dec 11, 2019
|
John Gilmore
Premium

NEW YORK – Researchers at the Colorado Center for Personalized Medicine's (CCPM) Biobank are collecting patient samples in order to analyze genetic data using SNP microarrays to provide pharmacogenetic (PGx) results. 

The CCPM has begun returning PGx test results to program participants, and will eventually deliver disease risk and carrier screening results. 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Jul
09
Featured Webinar

Our Magic DRAGEN: A Sequencing Lab Case Study on Accelerated Bioinformatics

Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program. 

Jul
22
Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
29
Featured Webinar

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector

Sponsored by
Illumina

“If we build it, they will come” is a familiar refrain that echoes in life science entrepreneurial circles. Too frequently startups believe that if a technology is built it will sell.

Sep
17
Featured Webinar

Clinical Diagnosis of Developmental Disorders with Chromosomal Microarrays

Sponsored by
Thermo Fisher Scientific

The prevalence of developmental disability among US children aged 3 to 17 years increased between 2009 and 2017, with as many as 1 in 6 children in the US reported to have a developmental disability diagnosis.

What's Popular?

In Informatics

  1. Foundation Medicine Shifts Focus to Early Cancer Detection With Lexent Bio Acquisition

    Premium

  2. NIH Allocates $75M to Create eMERGE Risk Assessment Network

  3. Genomics England, Sano, Zetta Building Platform to Support Rare Disease Patient Participation

    Premium

  4. RenalytixAI Inks Kidney Disease Dx Deals With University of Michigan, Global Pharmaceutical Firm

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.